Novel Treatments and Emerging Targets for Hepatocellular Carcinoma (HCC)

Renu Dhanasekaran, MD

Supported by educational grants from Bristol-Myers Squibb, Eisai and Merck.

This recorded webinar is for educational purposes only and is non-accredited.